Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Congresswoman Questions FDA Decision On Mentor Implant Study

This article was originally published in The Gray Sheet

Executive Summary

Rep. Rosa DeLauro, D-Conn., is questioning FDA's decision in May to allow patients getting Mentor's MemoryGel silicone breast implant to opt out of the firm's 10-year post-approval safety study

You may also be interested in...



House Ag Approps Chair Threatens FDA Management On Safety Role

The chair of the House Appropriations Agriculture Subcommittee is threatening to zero-out salaries of FDA center directors and heads of offices in fiscal 2008 as a consequence of failing to follow through on safety investigations

Silicone Breast Implant Approvals Conditioned On Huge Postmarket Studies

FDA's Nov. 17 approval of silicone-gel breast implants comes with the requirement for one of the largest post-approval studies ever called for by the device center, according to CDRH Director Dan Schultz

QUOTED. 3 April 2020. Minetta Liu.

Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.

Topics

UsernamePublicRestriction

Register

MT025361

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel